This announcement is a separate document:
永泰生物-B:首席財務官、公司秘書及授權代表辭任及委任聯席公司秘書及授權代表以及豁免嚴格遵守上市規則第3.28及8.17條
IMMUNOTECH-B: RESIGNATION OF CHIEF FINANCIAL OFFICER,COMPANY SECRETARY AND AUTHORISED REPRESENTATIVEANDAPPOINTMENT OF JOINT COMPANY SECRETARIES ANDAUTHORISED REPRESENTATIVE ANDWAIVER FROM STRICT COMPLIANCEWITH RULES 3.28 AND 8.17 OF THE LISTING RULES
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.